Related Experiment Video
Updated: Mar 9, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Diagnosing early cognitive decline-When, how and for whom?
Charlotte L Allan1, Sophie Behrman2, Klaus P Ebmeier2
1Centre for the Health of the Elderly, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, UK.
Abstract:
Mild cognitive impairment (MCI) is a term used to describe cognitive impairment in one or more cognitive domains that is greater than any expected age-related changes, but not of the magnitude to warrant a diagnosis of dementia. This review considers how early cognitive decline is diagnosed, focusing on the use of neuropsychological tests and neuroimaging, as well as the differential diagnosis. Potential treatments, including secondary prevention, post-diagnostic support and self-help are discussed. Finally, medico-legal matters such as driving, lasting power of attorney and employment are outlined.
Insights
Mild cognitive impairment (MCI) involves noticeable cognitive decline beyond normal aging, but not dementia. This review covers diagnosis, treatments, and legal issues for individuals experiencing early cognitive changes.
Area of Science:
- Neurology
- Geriatrics
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) signifies cognitive deficits exceeding age-expected changes, distinct from dementia.
- Early identification of cognitive decline is crucial for timely intervention and management.
- Understanding MCI is vital for addressing the growing needs of an aging global population.
Purpose of the Study:
- To review diagnostic approaches for early cognitive decline, specifically mild cognitive impairment (MCI).
- To explore available treatments and support systems for individuals with MCI.
- To outline medico-legal considerations relevant to cognitive impairment.
Main Methods:
- Review of current literature on mild cognitive impairment (MCI) diagnosis.
- Analysis of neuropsychological tests and neuroimaging techniques for cognitive assessment.
- Examination of treatment strategies and medico-legal implications.
Main Results:
- Neuropsychological tests and neuroimaging are key tools for diagnosing MCI.
- Differential diagnosis is essential to distinguish MCI from other conditions.
- A range of treatments, including prevention and support, can be offered.
- Medico-legal aspects impact daily life, including driving and employment.
Conclusions:
- Accurate diagnosis of mild cognitive impairment (MCI) relies on comprehensive assessment.
- Early intervention and ongoing support are vital for managing MCI.
- Addressing medico-legal issues is a critical component of comprehensive MCI care.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Language and Cognition